So-Young To Report First Quarter 2022 Financial Results On May 23, 2022


(MENAFN- GlobeNewsWire - Nasdaq)

BEIJING, May 16, 2022 (GLOBE NEWSWIRE) -- So-Young International Inc. (NASDAQ: SY) (“So-Young” or the“Company”), the largest and most vibrant social community in China for consumers, professionals and service providers in the medical aesthetics industry, today announced that it will report its financial results for the first quarter ended March 31, 2022, before U.S. markets open on May 23, 2022. The earnings release will be available on the investor relations page of the Company's website at

About So-Young

So-Young International Inc. (Nasdaq: SY) (“So-Young” or the“Company”) is the largest and most vibrant social community in China for consumers, professionals and service providers in the medical aesthetics industry. The Company presents users with reliable information through offering high quality and trustworthy content together with a multitude of social functions on its platform, as well as by curating medical aesthetic service providers that are carefully selected and vetted. Leveraging So-Young's strong brand image, extensive audience reach, trust from its users, highly engaging social community and data insights, the Company is well-positioned to expand both along the medical aesthetic industry value chain and into the massive, fast-growing consumption healthcare service market.

For more information, please contact:

So-Young

Investor Relations
Ms. Vivian XU
Phone: +86-10-8790-2012
E-mail:

Christensen

In China
Mr. Eric Yuan
Phone: +86-10-5900-1548
E-mail:

In US
Ms. Linda Bergkamp
Phone: +1-480-614-3004
Email:




MENAFN16052022004107003653ID1104220295


Legal Disclaimer:
MENAFN provides the information “as is” without warranty of any kind. We do not accept any responsibility or liability for the accuracy, content, images, videos, licenses, completeness, legality, or reliability of the information contained in this article. If you have any complaints or copyright issues related to this article, kindly contact the provider above.